Insurance Trust Fund Sues Allergan for Anticompetitive Practices

Drug Industry Daily
A A
A class of indirect purchasers filed an antitrust suit against Allergan over the transfer of its Restasis patents to the St. Regis Mohawk tribe and other anticompetitive practices that inflated the drug’s price.

To View This Article:

Login

Subscribe To Drug Industry Daily